Kaimi Biopharma
凯米生物
Kaimi Biopharma
Biotech/Healthcare
Kaimi Biotech develops advanced antiviral and anticancer immunotherapies, with a focus on innovative treatments for refractory diseases. Its proprietary SynNeogen vaccine platform combines antigen and antibody characteristics and can simulate the body’s natural process of antigen uptake…
Latest round: Pre Series A (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-07-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.